Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancerN. Lynn Henry, David A. Flockhart, Anne Nguyen et al.|Breast Cancer Research and Treatment|2013Cited by 64
Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnoverSteffi Oesterreich, David A. Flockhart, N. Lynn Henry et al.|Breast Cancer Research and Treatment|2015Cited by 35
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effectsN. Lynn Henry, Vered Stearns, Jessica Dantzer et al.|British Journal of Cancer|2013Cited by 29